How much does the Indian version of Necitumumab cost?

It is understood that there is no original or generic Indian version of Necitumumab produced and marketed, but Necitumumab produced in other countries may be marketed in India. Necitumumab is indicated in combination with gemcitabine and cisplatin for the first-line treatment of patients with metastatic squamous non-small cell lung cancer (NSCLC) that has spread to other parts of the body. Nexituzumab injection belongs to a class of drugs called monoclonal antibodies. It works by helping your immune system slow or stop the growth of cancer cells.